These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16638566)

  • 61. Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells.
    Qin ZL; Zhao P; Zhang XL; Yu JG; Cao MM; Zhao LJ; Luan J; Qi ZT
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1186-93. PubMed ID: 15504339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of a novel coronavirus associated with severe acute respiratory syndrome.
    Rota PA; Oberste MS; Monroe SS; Nix WA; Campagnoli R; Icenogle JP; Peñaranda S; Bankamp B; Maher K; Chen MH; Tong S; Tamin A; Lowe L; Frace M; DeRisi JL; Chen Q; Wang D; Erdman DD; Peret TC; Burns C; Ksiazek TG; Rollin PE; Sanchez A; Liffick S; Holloway B; Limor J; McCaustland K; Olsen-Rasmussen M; Fouchier R; Günther S; Osterhaus AD; Drosten C; Pallansch MA; Anderson LJ; Bellini WJ
    Science; 2003 May; 300(5624):1394-9. PubMed ID: 12730500
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses.
    Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An interaction between the nucleocapsid protein and a component of the replicase-transcriptase complex is crucial for the infectivity of coronavirus genomic RNA.
    Hurst KR; Ye R; Goebel SJ; Jayaraman P; Masters PS
    J Virol; 2010 Oct; 84(19):10276-88. PubMed ID: 20660183
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.
    Hertzig T; Scandella E; Schelle B; Ziebuhr J; Siddell SG; Ludewig B; Thiel V
    J Gen Virol; 2004 Jun; 85(Pt 6):1717-1725. PubMed ID: 15166457
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein.
    McBride CE; Li J; Machamer CE
    J Virol; 2007 Mar; 81(5):2418-28. PubMed ID: 17166901
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interferon-beta 1a and SARS coronavirus replication.
    Hensley LE; Fritz LE; Jahrling PB; Karp CL; Huggins JW; Geisbert TW
    Emerg Infect Dis; 2004 Feb; 10(2):317-9. PubMed ID: 15030704
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model.
    de Wilde AH; Falzarano D; Zevenhoven-Dobbe JC; Beugeling C; Fett C; Martellaro C; Posthuma CC; Feldmann H; Perlman S; Snijder EJ
    Virus Res; 2017 Jan; 228():7-13. PubMed ID: 27840112
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition.
    Han YS; Chang GG; Juo CG; Lee HJ; Yeh SH; Hsu JT; Chen X
    Biochemistry; 2005 Aug; 44(30):10349-59. PubMed ID: 16042412
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of SARS-associated coronavirus infection and replication by RNA interference.
    He ML; Zheng B; Peng Y; Peiris JS; Poon LL; Yuen KY; Lin MC; Kung HF; Guan Y
    JAMA; 2003 Nov; 290(20):2665-6. PubMed ID: 14645307
    [No Abstract]   [Full Text] [Related]  

  • 72. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
    Yi CE; Ba L; Zhang L; Ho DD; Chen Z
    J Virol; 2005 Sep; 79(18):11638-46. PubMed ID: 16140741
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism.
    Hussain S; Perlman S; Gallagher TM
    J Virol; 2008 Jul; 82(14):7212-22. PubMed ID: 18448520
    [TBL] [Abstract][Full Text] [Related]  

  • 74. On the mechanisms of bananin activity against severe acute respiratory syndrome coronavirus.
    Wang Z; Huang JD; Wong KL; Wang PG; Zhang HJ; Tanner JA; Spiga O; Bernini A; Zheng BJ; Niccolai N
    FEBS J; 2011 Jan; 278(2):383-9. PubMed ID: 21134131
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting the pseudorabies virus DNA polymerase processivity factor UL42 by RNA interference efficiently inhibits viral replication.
    Wang YP; Huang LP; Du WJ; Wei YW; Wu HL; Feng L; Liu CM
    Antiviral Res; 2016 Aug; 132():219-24. PubMed ID: 27387827
    [TBL] [Abstract][Full Text] [Related]  

  • 76. siRNA Targeting the 2Apro Genomic Region Prevents Enterovirus 71 Replication In Vitro.
    Liu H; Qin Y; Kong Z; Shao Q; Su Z; Wang S; Chen J
    PLoS One; 2016; 11(2):e0149470. PubMed ID: 26886455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recognition and analysis of protein-coding genes in severe acute respiratory syndrome associated coronavirus.
    Sharma R; Maheshwari JK; Prakash T; Dash D; Brahmachari SK
    Bioinformatics; 2004 May; 20(7):1074-80. PubMed ID: 14764577
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
    Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
    Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recent patents on treatment of severe acute respiratory syndrome (SARS).
    Zhai S; Liu W; Yan B
    Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):1-10. PubMed ID: 18221160
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells.
    Mossel EC; Wang J; Jeffers S; Edeen KE; Wang S; Cosgrove GP; Funk CJ; Manzer R; Miura TA; Pearson LD; Holmes KV; Mason RJ
    Virology; 2008 Mar; 372(1):127-35. PubMed ID: 18022664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.